BIODESIX

Details for Australian Trade Mark No. 1464427 (hide)

Classes

Class 42 Scientific research services; medical research services; scientific testing services; research and discovery services related to developing prognostic and predictive tests to determine whether patients or a subgroup of patients are likely to benefit from treatment with therapies or combination of therapies intended to treat a disease or disorder, including anti-cancer drugs for cancer; laboratory testing services, including providing prognostic and predictive tests to determine whether patients or a subgroup of patients are likely to benefit from treatment with therapies or combination of therapies intended to treat a disease or disorder, including anti-cancer drugs for cancer, based on mass spectral analysis of clinical specimens; providing an interactive website to provide information regarding tests prognostic or predictive of patient benefit from treatment with therapies or combination of therapies, including anticancer drugs for cancer; test results reports providing results of test services, namely reports indicating whether a patient is likely to benefit from treatment with therapies or combination of therapies intended to treat a disease or disorder, including anticancer drugs for cancer

Event Publications

22 December 2011 Application filed

7 June 2012 Application Accepted

20 September 2012 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.